Cambridge Healthtech Institute’s 11th Annual

Formulation and Delivery of High-Concentration Proteins and New Modalities

Strategies to Overcome Challenges in Viscosity, Aggregation, and Delivery

August 21-22, 2024


The 11th Annual Formulation and Delivery of High-Concentration Proteins and New Modalities conference will bring together industry leaders, researchers, and innovators to share knowledge and foster dialogue and collaborations. The conference will focus on high-concentration protein formulations to unravel formulation strategies leveraging AI/ML, predictive tools, and innovative excipients. Additionally, the experts in the field will share their strategies for the formulation and delivery of cell and gene therapies and non-traditional modalities featuring oligonucleotide therapeutics, prime editing, nanoparticle-based therapeutics, and more. Furthermore, we’ll delve into the drug-device combination and smart drug delivery devices to share success stories of the integration of smart technologies for real-time monitoring and enhanced patient experiences. We are seeking case studies, unpublished work, new technologies, and winning strategies to feature on the agenda.


Coverage will include, but is not limited to:


1) High-Concentration Protein Formulations:

  • Formulation approaches to overcome challenges posed by high-viscosity
  • Use of AI/ML in formulation design, development, and quality
  • Tools for prediction and high-throughput measurement of aggregation, viscosity, and solubility
  • Innovative excipient development that improves stability, solubility, and reduces immunogenicity

2) Drug-Device Combination and Smart Drug Delivery Devices:

  • Integration of smart technologies into drug delivery devices for real-time monitoring, dose adjustment, and patient engagement
  • Connected devices and digital health solutions to enhance the overall patient experience
  • Methods for assessment of the developability of combination devices

3) Formulation and Delivery of Cell and Gene Therapy

4) Formulation and Delivery of Non-Traditional Modalities

  • Oligonucleotide therapeutics
  • Prime editing and base editing
  • Nanoparticle-based therapeutics
  • Exosome therapeutics
  • Lipid Nanoparticle (LNP) formulations
  • Non-viral delivery systems   


The deadline for priority consideration is February 2, 2024.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


Opportunities for Participation:



For more details on the conference, please contact:

Nandini Kashyap

Senior Director, Conferences and Social Media Strategy

Cambridge Healthtech Institute

Phone: (+1) 781-972-5406



For sponsorship information, please contact:

Companies A-K

Phillip Zakim-Yacouby

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-247-1815



Companies L-Z

Aimee Croke

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-292-0777